Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vascular access challenges in hemodialysis children. | Ital J Pediatr | 2024 | 38254126 | PubTator, text mining | PubMed |
| Metabolic Regulations of Smilax china L. against β-Amyloid Toxicity in Caenorhabditis elegans. | Metabolites | 2024 | 38248852 | PubTator, text mining | PubMed |
| Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants. | FEBS Lett | 2024 | 38243391 | PubTator, text mining | PubMed |
| Single-cell RNA-Seq Elucidates the Crosstalk Between Cancer Stem Cells and the Tumor Microenvironment in Hepatocellular Carcinoma. | J Cancer | 2024 | 38230205 | PubTator, text mining | PubMed |
| Amino acid metabolism in tumor biology and therapy. | Cell Death Dis | 2024 | 38218942 | PubTator, text mining | PubMed |
| Changing trends in phase 1 oncology clinical trials. | Contemp Clin Trials Commun | 2024 | 38204884 | PubTator, text mining | PubMed |
| Glyoxylate reductase: Definitive identification in human liver mitochondria, its importance for the compartment-specific detoxification of glyoxylate. | J Inherit Metab Dis | 2024 | 38200664 | PubTator, text mining | PubMed |
| Palmar papules as a manifestation of cutaneous oxalosis in primary hyperoxaluria: A case report and review of the literature. | Clin Case Rep | 2024 | 38188849 | PubTator, text mining | PubMed |
| TYROBP as a molecular target in cholangiocarcinoma, renal cancer and abdominal aortic aneurysm. | Medicine (Baltimore) | 2024 | 38181271 | PubTator, text mining | PubMed |
| Carrier frequency estimation of pathogenic variants of autosomal recessive and X-linked recessive mendelian disorders using exome sequencing data in 1,642 Thais. | BMC Med Genomics | 2024 | 38167091 | PubTator, text mining | PubMed |
| Three kingdoms and one ceramide to rule them all. A comparison of the structural basis of ceramide-dependent regulation of sphingolipid biosynthesis in animals, plants, and fungi. | Adv Biol Regul | 2024 | 38135565 | PubTator, text mining | PubMed |
| The Clinical and Pathological Characteristics of Patients with Oxalate Nephropathy. | Kidney360 | 2024 | 38095544 | PubTator, text mining | PubMed |
| Overexpression of ORMDL3 confers sexual dimorphism in diet-induced non-alcoholic steatohepatitis. | Mol Metab | 2024 | 38081412 | PubTator, text mining | PubMed |
| Recurrent de-novo gain-of-function mutation in SPTLC2 confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosis. | J Neurol Neurosurg Psychiatry | 2024 | 38041684 | PubTator, text mining | PubMed |
| Recurrent de novo SPTLC2 variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis. | J Neurol Neurosurg Psychiatry | 2024 | 38041679 | PubTator, text mining | PubMed |
| Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma. | FEBS Open Bio | 2024 | 37964489 | PubTator, text mining | PubMed |
| Primary Hyperoxaluria Screening and Monitoring: Quantitative Measurement of Plasma Oxalate by Gas Chromatography-Mass Spectrometry With High Sensitivity. | Ann Lab Med | 2024 | 37904578 | PubTator, text mining | PubMed |
| A clinical screening algorithm for primary hyperoxaluria type 1 in adults on dialysis. | Nephrol Dial Transplant | 2024 | 37708050 | PubTator, text mining | PubMed |
| The 20th Biennial congress of the South African Society of Nuclear Medicine conference report. | J Coll Med S Afr | 2023 | 40950389 | PubTator, text mining | PubMed |
| Genotype and Phenotype Characteristics of Chinese Pediatric Patients with Primary Hyperoxaluria. | Hum Mutat | 2023 | 40225159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=14